12:00 AM
 | 
Apr 07, 2008
 |  BioCentury  |  Finance

Results by market cap

Results by market cap

Every market cap segment for biotech was down more than 9% last quarter. The...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >